Nyavanandi; Vijay Kumar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nyavanandi; Vijay Kumar.The latest application filed is for "quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathways".

Company Profile

8.7.10

Nyavanandi; Vijay Kumar - Hyderabad IN
Nyavanandi; Vijay Kumar - Andhra Pradesh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinazolines And Azaquinazolines As Dual Inhibitors Of Ras/raf/mek/erk And Pi3k/akt/pten/mtor Pathways App 20210113578 - Thompson; Scott K. ; et al.	2021-04-22
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways Grant 10,912,779 - Thompson , et al. February 9, 2	2021-02-09
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways Grant 10,869,872 - Thompson , et al. December 22, 2	2020-12-22
Tetrasubstituted alkene compounds and their use Grant 10,851,065 - Bock , et al. December 1, 2	2020-12-01
Tetrasubstituted Alkene Compounds And Their Use For The Treatment Of Breast Cancer App 20200255415 - Kind Code	2020-08-13
Tetrasubstituted Alkene Compounds And Their Use App 20190337921 - Bock; Mark ; et al.	2019-11-07
Quinazolines And Azaquinazolines As Dual Inhibitors Of Ras/raf/mek/erk And Pi3k/akt/pten/mtor Pathways App 20190151327 - Thompson; Scott K. ; et al.	2019-05-23
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways Grant 10,226,468 - Thompson , et al.	2019-03-12
Tetrasubstituted Alkene Compounds And Their Use App 20180141913 - BOCK; Mark ; et al.	2018-05-24
Tetrasubstituted Alkene Compounds And Their Use App 20180127378 - BOCK; Mark ; et al.	2018-05-10
Tetrasubstituted alkene compounds and their use Grant 9,796,683 - Bock , et al. October 24, 2	2017-10-24
Quinazolines And Azaquinazolines As Dual Inhibitors Of Ras/raf/mek/erk And Pi3k/akt/pten/mtor Pathways App 20170290838 - Thompson; Scott K. ; et al.	2017-10-12
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways Grant 9,757,382 - Thompson , et al. September 12, 2	2017-09-12
Quinazolines And Azaquinazolines As Dual Inhibitors Of Ras/raf/mek/erk And Pi3k/akt/pten/mtor Pathways App 20170027953 - Thompson; Scott K. ; et al.	2017-02-02
Tetrasubstituted Alkene Compounds And Their Use App 20160347717 - BOCK; Mark ; et al.	2016-12-01
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways Grant 9,499,495 - Thompson , et al. November 22, 2	2016-11-22
Quinazolines And Azaquinazolines As Dual Inhibitors Of Ras/raf/mek/erk And Pi3k/akt/pten/mtor Pathways App 20160068496 - Thompson; Scott K. ; et al.	2016-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.